Literature DB >> 22031309

Detection of genomic abnormalities in multiple myeloma: the application of FISH analysis in combination with various plasma cell enrichment techniques.

Luise Hartmann1, Julie Sanford Biggerstaff, Douglas B Chapman, Janice M Scott, Krystal R Johnson, Keely M Ghirardelli, Wayne K Fritschle, Dolores L Martinez, Richard K Bennington, Monica E de Baca, Denise A Wells, Michael R Loken, Barbara K Zehentner.   

Abstract

Multiple myeloma (MM) is a hematopoietic neoplasm characterized by malignant plasma cells (PCs) that accumulate in the bone marrow. A number of different genomic abnormalities are associated with MM; however, detection of these by fluorescence in situ hybridization (FISH) can be limited by the percentage of PCs in the specimen. In this study, we tested 20 bone marrow specimens with known MM and a low concentration of monoclonal PCs for the presence of genomic abnormalities using FISH in combination with various PC enrichment techniques: magnetic cell sorting, targeted manual scoring, and automated image analysis. In addition, flow cytometric cell sorting of PCs in combination with FISH analysis was also tested for minimal residual disease applications. Different parameters were evaluated when assessing the detection efficiency of each approach. FISH results are highly dependent on the chosen enrichment method. We describe the evaluation of different techniques applicable for various laboratory settings and specimen parameters.

Entities:  

Mesh:

Year:  2011        PMID: 22031309     DOI: 10.1309/AJCPF7NFLW8UAJEP

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

Review 1.  What we mean when we talk about MRD in myeloma. A review of current methods. Part 1 of a two-part series.

Authors:  Scott Ely; Noa Biran; Ajai Chari
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

2.  Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma.

Authors:  Jihye Ha; Hyunsoo Cho; Taek Gyu Lee; Saeam Shin; Haerim Chung; Ji Eun Jang; Soo-Jeong Kim; June-Won Cheong; Seung-Tae Lee; Jin Seok Kim; Jong Rak Choi
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

3.  Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone.

Authors:  Meletios A Dimopoulos; Katja C Weisel; Kevin W Song; Michel Delforge; Lionel Karlin; Hartmut Goldschmidt; Philippe Moreau; Anne Banos; Albert Oriol; Laurent Garderet; Michele Cavo; Valentina Ivanova; Adrian Alegre; Joaquin Martinez-Lopez; Christine Chen; Andrew Spencer; Stefan Knop; Nizar J Bahlis; Christoph Renner; Xin Yu; Kevin Hong; Lars Sternas; Christian Jacques; Mohamed H Zaki; Jesus F San Miguel
Journal:  Haematologica       Date:  2015-08-06       Impact factor: 9.941

4.  Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions.

Authors:  Jingquan Han; Shouqiang Cao; Kai Zhang; Guibin Zhao; Yanzhong Xin; Qing Dong; Yubo Yan; Jian Cui
Journal:  J Cardiothorac Surg       Date:  2012-11-13       Impact factor: 1.637

5.  Target fluorescence in-situ hybridization (Target FISH) for plasma cell enrichment in myeloma.

Authors:  Edmond S K Ma; Candy L N Wang; Anthony T C Wong; Gigi Choy; Tsun Leung Chan
Journal:  Mol Cytogenet       Date:  2016-08-16       Impact factor: 2.009

6.  Cytogenetic and FISH analysis of 93 multiple myeloma Moroccan patients.

Authors:  Hasna Hamdaoui; Oumaima Benlarroubia; Oum Kaltoum Ait Boujmia; Hossein Mossafa; Karim Ouldim; Aziza Belkhayat; Imane Smyej; Houda Benrahma; Hind Dehbi; Fatima Chegdani
Journal:  Mol Genet Genomic Med       Date:  2020-06-23       Impact factor: 2.183

7.  Validation of interphase fluorescence in situ hybridization (iFISH) for multiple myeloma using CD138 positive cells.

Authors:  Renata Kiyomi Kishimoto; Sarah Lee Vaughan Vulcani de Freitas; Cristina Alonso Ratis; Daniela Borri; Roberta Sitnik; Elvira Deolinda Rodrigues Pereira Velloso
Journal:  Rev Bras Hematol Hemoter       Date:  2016-02-23

Review 8.  Potential Clinical Application of Genomics in Multiple Myeloma.

Authors:  Cinnie Yentia Soekojo; Sanjay de Mel; Melissa Ooi; Benedict Yan; Wee Joo Chng
Journal:  Int J Mol Sci       Date:  2018-06-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.